gusperimus has been researched along with Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzdar, A; Dhingra, K; Fritsche, H; Grasela, D; Kelley, S; Khazaeli, MB; LoBuglio, AF; Murray, JL; Tepper, MA; Valero, V | 1 |
| Inagaki, J; Kimura, I; Majima, H; Masaoka, T; Niitani, H; Oguro, M; Ohno, R; Sanpi, K; Suzuoki, Y; Tamura, K | 1 |
| Boldt, DH; Brown, TD; Cagnola, J; Craig, JB; Harman, G; Havlin, KA; Koeller, J; Kuhn, JG; Phillips, J; Weiss, GR | 1 |
| Chace, D; Fell, HP; Liggitt, D; Siegall, CB; Tepper, MA | 1 |
| Booser, D; Buzdar, A; Dhingra, K; Fritsche, H; Greene, D; Kelley, S; Khazaeli, MB; LoBuglio, AF; Murray, JL; Tepper, M | 1 |
| Grasela, DM; Kelley, SL; Nadler, SG; Ramos, EL | 1 |
| Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
| Baltzer, L; Jakubowski, A; Lee, SJ; Muindi, JF; Riley, CM; Scher, HI; Sprancmanis, LA; Vander Velde, D; Young, CW | 1 |
| Dickneite, G; Schorlemmer, HU; Sedlacek, HH; Weinmann, E | 1 |
3 review(s) available for gusperimus and Neoplasms
| Article | Year |
|---|---|
Deoxyspergualin: mechanism of action and pharmacokinetics.
Topics: Animals; Antibody Formation; Arthritis, Rheumatoid; Cell Nucleus; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Multiple Sclerosis; Neoplasms; NF-kappa B; T-Lymphocytes | 1996 |
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
15-deoxyspergualin: from cytostasis to immunosuppression.
Topics: Animals; Antibiotics, Antineoplastic; Autoimmune Diseases; Guanidines; Humans; Immunosuppressive Agents; Neoplasms; Neoplasms, Experimental; Transplantation Immunology | 1988 |
5 trial(s) available for gusperimus and Neoplasms
| Article | Year |
|---|---|
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibody Formation; Complement Activation; Complement C3; Complement C4; Dose-Response Relationship, Drug; Drug Interactions; Female; Guanidines; Humans; Isoantigens; Male; Middle Aged; Neoplasms | 1995 |
Phase I study of NKT-01.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Guanidines; Hemoglobins; Humans; Leukemia; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Platelet Count; Regression Analysis | 1995 |
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Female; Guanidines; Humans; Hypotension; Male; Middle Aged; Neoplasms | 1995 |
Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study.
Topics: Adult; Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Formation; Female; Guanidines; Humans; Immunosuppressive Agents; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasms; Recombinant Fusion Proteins; Species Specificity | 1994 |
Clinical pharmacology of deoxyspergualin in patients with advanced cancer.
Topics: Animals; Antibiotics, Antineoplastic; Biotransformation; Cell Survival; Chromatography, High Pressure Liquid; Drug Evaluation; Guanidines; Humans; Infusions, Intravenous; Leukemia P388; Metabolic Clearance Rate; Mice; Neoplasms | 1991 |
1 other study(ies) available for gusperimus and Neoplasms
| Article | Year |
|---|---|
Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.
Topics: Animals; Antibodies, Monoclonal; Blood Vessels; Cyclosporine; Dexamethasone; Diphenhydramine; Female; Guanidines; Hematocrit; Humans; Hydrothorax; Immunosuppressive Agents; Immunotoxins; Lung; Macrophages, Alveolar; Neoplasms; Rats; Rats, Inbred WF; Rats, Nude; Recombinant Fusion Proteins; Transplantation, Heterologous | 1994 |